CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the immunology of liver metastases, particularly in colorectal cancer. By harnessing the biology of innate immune cells, it aims to develop novel immunotherapeutic strategies to improve treatment outcomes for patients with liver metastases.
Liver metastases commonly develop in up to 50% of patients with various cancer types.
The most common cancer that metastasizes to the liver is colorectal cancer (CRC).
At least 25% of CRC patients develop colorectal liver metastases (CRLM) during their illness. CRLM represent the major unmet clinical need for this malignancy, as the 5-year survival rate of patients with unresectable disease does not exceed 2%.
New therapies that promote antitumor immunity have been recently developed, mostly foc…
JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Marseille
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Milano
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Villejuif
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
